Charles River Laboratories International CRL
NYSE CRL
$296.78 +1.68 (+0.57%)
As of: Aug 27, 2026 · 3:59 PM EDT

Charles River Laboratories International (CRL) Cash from Investing Activities Growth (1y) (2010 - 2025)

Charles River Laboratories International (CRL) Cash from Investing Activities Growth (1y) (2010 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Growth (1y) (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 156.94%
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn -3,832.95%
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn -165.43%
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 32.46%
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn -10.12%
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 24.18%
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn -148.98%
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 95.92%
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn -289.16%
10 Charles River Laboratories International 14.28 Bn 14.09 Bn 452.07 Mn -

Historic Data

Download Data
DateValue
Dec 27, 2025 -21.95%
Sep 27, 2025 -58.02%
Jun 28, 2025 39.65%
Mar 29, 2025 46.99%
Dec 28, 2024 68.07%
Sep 28, 2024 73.20%
Jun 29, 2024 19.24%
Mar 30, 2024 49.12%
Dec 30, 2023 -637.08%
Sep 30, 2023 13.70%
Jul 1, 2023 83.42%
Apr 1, 2023 -72.05%
Dec 31, 2022 376.88%
Sep 24, 2022 74.04%
Jun 25, 2022 51.57%
Mar 26, 2022 28.98%
Dec 25, 2021 110.53%
Sep 25, 2021 -401.41%
Jun 26, 2021 -3,233.31%
Mar 27, 2021 66.64%